《Development and validation of a mass spectrometry binding assay for mGlu5 receptor》 was written by Ricart-Ortega, Maria; Berizzi, Alice E.; Catena, Juanlo; Malhaire, Fanny; Munoz, Lourdes; Serra, Carmen; Lebon, Guillaume; Goudet, Cyril; Llebaria, Amadeu. Name: 2,6-Dibromopyridine And the article was included in Analytical and Bioanalytical Chemistry in 2020. The article conveys some information:
Abstract: Mass spectrometry (MS) binding assays are a label-free alternative to radioligand or fluorescence binding assays, so the readout is based on direct mass spectrometric detection of the test ligand. The study presented here describes the development and validation of a highly sensitive, rapid, and robust MS binding assay for the quantification of the binding of the metabotropic glutamate 5 (mGlu5) neg. allosteric modulator (NAM), MPEP (2-methyl-6-phenylethynylpyridine) at the mGlu5 allosteric binding site. The LC-ESI-MS/MS (liquid chromatog.-electrospray ionization-tandem mass spectrometric) anal. method was established and validated with a deuterated analog of MPEP as an internal standard The developed MS binding assay described here allowed for the determination of MS binding affinity estimates that were in agreement with affinity estimates obtained from a tritiated MPEP radioligand saturation binding assay, indicating the suitability of this methodol. for determining affinity estimates for compounds that target mGlu5 allosteric binding sites. In the experimental materials used by the author, we found 2,6-Dibromopyridine(cas: 626-05-1Name: 2,6-Dibromopyridine)
2,6-Dibromopyridine(cas: 626-05-1) belongs to pyridine. Pyridine is a relatively complex molecule and exhibits a number of different bands in IR spectra. Among others, the bands characterizing the ν8a and ν19b modes have been found to be sensitive to the coordination or protonation of the molecule. Note that the band that is diagnostic for the PyH+ ion at about 1545 cm− 1 (ν19b mode) does not overlap with any of the other bands.Name: 2,6-Dibromopyridine